Thursday 12 July 2012

Simple Linctus Paediatric Sugar Free





1. Name Of The Medicinal Product



Simple Linctus Paediatric Sugar Free


2. Qualitative And Quantitative Composition



Citric Acid Monohydrate 31.25 mg/5 ml equivalent to 28.57 mg/5 ml Anhydrous Citric Acid.



3. Pharmaceutical Form



Clear Pink Sugar Free Syrup



4. Clinical Particulars



4.1 Therapeutic Indications



For the management of a mild non-specific cough.



4.2 Posology And Method Of Administration



Children: One or two 5 ml spoonfuls orally 3-4 times daily.



Adults: Not appropriate



4.3 Contraindications



Not known



4.4 Special Warnings And Precautions For Use



This medicine contains maltitol liquid. Patients with rare hereditary problems of fructose intolerance should not take this medicine



This medicinal product contains small amounts of ethanol (alcohol), less than 100mg per 5ml dose.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



Not known



4.6 Pregnancy And Lactation



Not Appropriate



4.7 Effects On Ability To Drive And Use Machines



Not Applicable



4.8 Undesirable Effects



Not Applicable



4.9 Overdose



Sufficient prolonged overdose of citric acid may cause erosion of the teeth and have a local irritant action.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Absorption: Citric Acid Monohydrate is absorbed after oral administration.



Distribution: Citric Acid is found naturally in the body and is widely distributed, about 70% of the citric acid in the body is in hard bone and this accounts for 1.5% of bone content.



Metabolic Reactions: It is an important intermediate in carbohydrate metabolism and its major role is in the tricarboxylic acid cycle (Krebs citric acid cycle); it is metabolised to carbon dioxide and water.



Excretion: Citric acid is normally excreted in the urine in amounts ranging from 0.4 to 1.5g daily and this amount is not increased unless very large doses are administered. The urinary excretion of citric acid is increased in alkaline urine



5.2 Pharmacokinetic Properties



Not applicable



5.3 Preclinical Safety Data



None stated



6. Pharmaceutical Particulars



6.1 List Of Excipients



Glycerol (E422)



Sodium Carboxymethylcellulose



Sodium Benzoate (E211)



Saccharin Sodium (E954)



Lycasin 80/55 (E965)



Ethanol (96%)



Anise Oil



Chloroform



Natural Red DI (E163)



Purified Water



6.2 Incompatibilities



Not appropriate



6.3 Shelf Life



2 years



6.4 Special Precautions For Storage



Store below 20°C.



6.5 Nature And Contents Of Container



Amber glass bottles with pilfer screw closure



High density Polyethylene with screw on closure



Pack sizes of 100 ml, 125 ml, 200 ml for Amber Glass Bottles



Pack size of 2000 ml for High Density Polyethylene dispensary pack.



6.6 Special Precautions For Disposal And Other Handling



As with all medicines.



7. Marketing Authorisation Holder



Pinewood Laboratories Limited



Ballymacarbry



Clonmel



Co Tipperary



8. Marketing Authorisation Number(S)



PL 04917/0007



9. Date Of First Authorisation/Renewal Of The Authorisation



28 August 1991



10. Date Of Revision Of The Text



November 2008




No comments:

Post a Comment